Related Experiment Video

Updated: May 9, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients

Michael Hecker1, Madhan Thamilarasan, Dirk Koczan

  • 1Steinbeis Transfer Center for Proteome Analysis, Schillingallee 68, 18057 Rostock, Germany. michael.hecker@rocketmail.com

International Journal of Molecular Sciences
|August 8, 2013
PubMed

Insights

Interferon-beta (IFN-beta) therapy for multiple sclerosis (MS) alters microRNA (miRNA) expression in immune cells. These changes, particularly mir-29 family down-regulation, suggest miRNAs are key to IFN-beta

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial post-transcriptional gene regulators implicated in diseases like multiple sclerosis (MS).
  • Interferon-beta (IFN-beta) is a primary immunomodulatory treatment for MS patients.
  • Understanding miRNA dynamics during IFN-beta therapy is vital for elucidating treatment mechanisms.

Purpose of the Study:

  • To conduct the first longitudinal analysis of miRNA expression changes in response to IFN-beta therapy in MS patients.
  • To investigate the role of miRNAs in the therapeutic effects of IFN-beta.
  • To identify potential miRNA biomarkers for IFN-beta treatment response and disease progression.

Main Methods:

  • Longitudinal sampling of peripheral blood mononuclear cells (PBMCs) from MS patients (CIS and RRMS) before and after IFN-beta initiation (2 days, 4 days, 1 month).
  • Parallel measurement of 651 mature miRNAs and approximately 19,000 mRNAs using real-time PCR arrays and Affymetrix microarrays.
  • Bioinformatic analysis to construct miRNA-mRNA interaction networks and identify differentially expressed miRNAs and their associated pathways.

Main Results:

  • IFN-beta therapy led to the down-regulation of specific miRNAs, including the mir-29 family, concurrent with the up-regulation of IFN-beta-responsive genes.
  • Differentially expressed miRNAs were significantly associated with apoptotic processes and interferon feedback mechanisms.
  • A comprehensive miRNA-mRNA interaction network revealed potential regulatory pathways influenced by IFN-beta treatment.

Conclusions:

  • miRNA-mediated gene regulation is a significant component of IFN-beta's mechanism of action in MS treatment and normal immune responses.
  • Longitudinal miRNA expression profiling in blood may serve as a predictive biomarker for IFN-beta therapy's biological impact, disease activity, and progression in MS.
  • This study highlights the therapeutic potential of targeting miRNA pathways in managing multiple sclerosis.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...